)
)
Procaps Group Investor Relations Material
Latest events
Investor Update
Procaps Group
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Procaps Group S.A.
Access all reports
Procaps Group S.A. is a healthcare and pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical solutions globally. The company's product offerings include branded prescription drugs across various therapeutic areas, over-the-counter (OTC) consumer healthcare products, and high-potency clinical compounds. Additionally, Procaps provides contract drug development and manufacturing services, specializing in soft gelatin capsule technologies. The company's operations are organized into several units, such as Diabetrics, which focuses on diabetes solutions, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties, each catering to specific healthcare needs. The company is headquartered in Luxembourg, and its shares are listed on the NASDAQ.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
PROC
Country
🇺🇸 United States